Tesamorelin is tracked as a US research-market identity, not as an authorization or local supply finding for Singapore.
Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
Tesamorelin is tracked as a US research-market identity, not as an authorization or local supply finding for Singapore. Match the exact category, legal seller identity, and claimed route against the official records on this page.
Resolve the exact identity of Tesamorelin through Check the FDA Purple Book product record from U.S. Food and Drug Administration. Then search HSA Infosearch from Singapore Health Sciences Authority for the destination product record and Supply through e-pharmacy from Singapore Health Sciences Authority for the seller, establishment, or supply route in Singapore. A match in one record does not replace the other two checks.
No. A page using the name Tesamorelin, local currency, a domestic delivery claim, or a familiar package image is only a lead. This record resolves seller-labelled 10 mg tesamorelin research listings. EGRIFTA WR is a separate FDA-licensed prescription product with a specific application, 11.6 mg presentation, indication, label, and regulated supply chain. The research listings do not inherit that approval. For Singapore, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
Tesamorelin is tracked as a US research-market identity, not as an authorization or local supply finding for Singapore. Match the exact category, legal seller identity, and claimed route against the official records on this page.
Primary identity source: Check the FDA Purple Book product record / U.S. Food and Drug Administration ↗A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
Check the FDA Purple Book product record is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Check the FDA Purple Book product record ↗HSA Infosearch is maintained by Singapore Health Sciences Authority. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open HSA Infosearch ↗Supply through e-pharmacy is maintained by Singapore Health Sciences Authority. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Supply through e-pharmacy ↗Singapore's HSA publishes distinct records for therapeutic products, health-product dealers, poisons licences, retail pharmacies, and illegal health products. A clinic page, marketplace listing, supplement description, or Singapore domain does not resolve all of those checks.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
Use HSA Infosearch and the Register of Therapeutic Products to match the exact product, registration details, holder, and status rather than inferring authorization from an ingredient or overseas brand.
Search HSA's licensed importer, wholesaler, manufacturer, poisons-licence, and retail-pharmacy records for the legal entity behind the offer. Each register covers a different activity.
For electronic prescription supply, confirm the named platform appears with the licensed pharmacy and follows HSA's closed-loop prescription and local licensing requirements.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.